Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

Share Price is delayed by 15 minutes
Get Live Data
325.00    -8.00 (-2.40%)
Bid:
320.00
Ask:
330.00
Spread: 10.00 (3.125%)
Market Cap: £41.24m
SYS1 Live PriceLast checked at - London Stock Exchange

Intraday System1 Group Share Chart

Shareholder update & PDMR Dealing

2 Mar 2026 13:39

RNS Number : 9731U
System1 Group PLC
02 March 2026
Β 

Β 

Β 

Β 

Β 

2 March 2026

Β 

System1 Group PLC (AIM: SYS1)

Β ("System1", or "the Company", or "the Group")

Β 

Shareholder update & PDMR Dealing

The board of System1 Group PLC (the "Board") (AIM: SYS1), notes the announcement released today by Brave Bison Group plc ("Brave Bison") in relation to its strategic investment in the Company and in particular notes the following:

Β· John Kearon, System1's Founder and Non-Executive Director has sold 2,919,793 shares in System1 representing 23.01% of the Company's issued share capital to Brave Bison (the "Disposal"), at an implied System1 share price of 248.64 pence;

Β· Consideration for the Disposal is the issue of 9,810,504 ordinary shares in Brave Bison representing 8.74% of Brave Bison's enlarged issued share capital; and

Β· Brave Bison now holds 3,547,904 shares in System1, equivalent to approximately 27.96% of the Company's issued share capital, including 628,111 System1 shares purchased on market at a price of 210 pence per share in cash, which in aggregate is a blended price per System1 share of 241.80 pence.

The Board acknowledges the strategic investment by Brave Bison in System1. The Board notes that Brave Bison is supportive of the strategy of System1 and is looking forward to engaging with Brave Bison in their support of the execution of the Company's strategy.

The Board confirms that the Company continues to trade in line with the guidance as announced on 20 January 2026.

Following the Disposal, John Kearon will no longer hold any shares in System1.

The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.

This announcement contains inside information for the purposes of article 7 of the Market Abuse Regulation (EU) 596/2014 as amended by regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310. With the publication of this announcement, this information is now considered to be in the public domain.

-Ends-

Β 

For further information, please contact:

System1 Group PLC

Tel: +44 (0)7467 990147

James Gregory, Chief Executive Officer

Chris Willford, Chief Financial Officer

Canaccord Genuity Limited (Nominated Adviser and Joint Broker)

Tel: +44 (0)20 7523 8000

Simon Bridges / Andrew Potts / Harry Rees

Β 

Singer Capital Markets (Joint Broker)

Tel: +44 (0)20 7496 3000

James Moat / Sara Hale / James Fischer

Β 

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014

Β 

Β 

1.

Details of the Person discharging managerial responsibilities ("PDMR") / person closely associated with them ("PCA")

a)

Name

John Kearon

2.

Reason for the notification

a)

Position / status

Non-Executive Director

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

System1 Group PLC

b)

Legal Entity Identifier

213800TDLR42C3Q9ZB74

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares

GB00B1GVQH21

b)

Nature of the transaction

Sale of shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Β£2.4864

Β 

2,919,793 shares

Β 

d)

Aggregated information

- Aggregated volume

- Aggregated price

- Aggregated total

Β 

Not applicable

e)

Date of the transaction

2 March 2026

f)

Place of the transaction

London Stock Exchange

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHUUOORNNUORAR
Date   Source Headline
1st May 20264:30 pmRNSHolding(s) in Company
21st Apr 20267:01 amRNSRelationship Agreement with Brave Bison
21st Apr 20267:00 amRNSQ4 and Full Year Trading Update
9th Apr 20267:00 amRNS-RLaunch of next evolution of Test Your Ad platform
30th Mar 20264:30 pmRNSHolding(s) in Company
30th Mar 20263:30 pmRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSTrading Update
16th Mar 20267:00 amRNSTrading Update
5th Mar 20263:15 pmRNSDirector/PDMR Shareholding
3rd Mar 20265:15 pmRNSHolding(s) in Company
3rd Mar 20264:06 pmRNSBoard Change
2nd Mar 20261:39 pmRNSShareholder update & PDMR Dealing
2nd Mar 20267:00 amRNSDirectorate change
30th Jan 20261:00 pmRNSBoard Committee and Change of Role Update
20th Jan 20267:00 amRNSTrading Update
12th Jan 20264:45 pmRNSAppointment of Joint Corporate Broker
2nd Dec 20257:00 amRNSInterim Results
20th Nov 202511:45 amRNSHolding(s) in Company
24th Oct 20253:28 pmRNSHolding(s) in Company
22nd Oct 20257:00 amRNSTrading Update
14th Oct 20259:16 amRNSCapital Markets Day
6th Oct 20253:30 pmRNSDirector/PDMR Shareholding
30th Sep 20257:00 amRNSDirector/PDMR Shareholding - replacement
29th Sep 20255:48 pmRNSDirector/PDMR Shareholding
29th Sep 20251:27 pmRNSHolding(s) in Company
26th Sep 20252:29 pmRNSHolding(s) in Company
26th Sep 20257:00 amRNSDirector/PDMR Shareholding
24th Sep 20253:01 pmRNSResult of AGM
23rd Sep 20257:00 amRNSTrading Update
15th Sep 20251:00 pmRNSDirector/PDMR Shareholding
27th Aug 20254:51 pmRNSNotice of AGM
8th Aug 20254:35 pmRNSDirector/PDMR Shareholding
9th Jul 20257:00 amRNSDirector Role Change
9th Jul 20257:00 amRNSFinal Results
9th Jul 20257:00 amRNSTrading Update
4th Jul 202511:45 amRNSHolding(s) in Company
4th Jul 20257:00 amRNSHolding(s) in Company
16th Jun 20251:30 pmRNSHolding(s) in Company
14th May 20257:00 amRNSEstablishment of New Long-Term Incentive Plan
24th Apr 20251:53 pmRNSHolding(s) in Company
23rd Apr 20257:00 amRNSTrading Statement
23rd Jan 20257:00 amRNSHolding(s) in Company
21st Jan 20257:00 amRNSTrading Update
8th Jan 202510:15 amRNSHolding(s) in Company
3rd Dec 20247:00 amRNSInterim Results
28th Nov 20247:00 amRNSInterim Results Presentation
21st Nov 20243:31 pmRNSHolding(s) in Company
28th Oct 202410:15 amRNSDirector/PDMR Shareholding
23rd Oct 20247:00 amRNSDirector/PDMR Shareholding
22nd Oct 20247:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.